Discover Indiaā€™s Potential in Pharma market

$130 bn
Industry by 2030
Biosimilars
Fastest growing segment
3rd
Largest
API market in the world

THE DEMAND CATALYSTS

Major Key Trends in the Indian Pharmaceutical Market

Pharma Taevas

India is a major producer of generic drugs, which are copies of branded drugs that have lost their patent protection. Generic drugs are typically much cheaper than branded drugs, driving their growth in the Indian market.Ā 

Pharma Taevas

Biosimilars are copies of biologic drugs, which are made from living organisms. Biologic drugs are typically more expensive than traditional chemical drugs, but they are also more effective in treating certain diseases. The growing demand for biosimilars is being driven by the rising cost of biologic drugs and the need for more affordable treatment options.

Pharma Taevas

Digital health is the use of technology to improve healthcare. This includes the use of mobile apps, wearable devices, and big data analytics to track patients’ health, diagnose diseases, and deliver treatment. The rise of digital health is being driven by the increasing availability of technology and the growing demand for personalized healthcare.Ā 

Pharma Taevas

The Indian government is supporting the pharmaceutical sector by providing tax breaks and subsidies to research and development, this is expected to help the Indian pharmaceutical market to remain competitive in the global market.

Navigating Indian Pharmaceutical Regulatory Landscape

A Step-By-Step Guide to Pharmaceutical Product Registration

Step 1: Appoint an Indian Authorized Representative

Identify and appoint an Indian Authorized Representative who will be responsible for periodic follow-ups with the Health Authorities (HA) for the registration dossier.

Step 2: Ensure Access to the SUGAM Portal

Verify that the IAR has the required credentials to access the online SUGAM portal, essential for submitting various applications.

Step 3: Conduct Clinical Trials

Submit an application to conduct Phases I, II, and III of the clinical trials, carry out the clinical trials as per the approved application, and then submit the report of the clinical trials to the relevant Agency.

Step 4: Apply for Market Authorization Holding

Once the clinical trials are complete and the product has been found to be safe and effective, you can apply for marketing authorization from the CDSCO.

Step 5: Obtain the Import License

Submit an application to obtain the Import License, permitting the legal importation of the product into India.

Choose Your Speciality

Prescription Drugs
Over-the-Counter Drugs (OTC)
Biologics
Generics
Orphan Drugs
Our Services

Empowering your Success in the Indian Market ā€‹

Taevas is at the forefront of this expansion, supporting businesses as they navigate and conquer new markets. Our comprehensive range of services for the life sciences include

Market access solutions
Embarking on Success with Taevas

Embarking on Success with Taevas

Taevas stands ready to serve as your custom-fit partner in India, catering to your unique business requirements.

As Your Market Entry Partner
  • As your Indian Authorized Representative (IAR), we ensure your regulatory compliance
  • We identify potential distributors for your products and facilitate initial connections
  • You will lead the further development of these distributor relationships
As Your Commercial Partner
  • Along with being your IAR, we also act as your centralized distributor in India
  • We identify and appoint local distributors in different regions of India, creating a wide and efficient distribution network
  • You can focus on your core business, while we handle the complexities of distribution
As Your Operational Partner
  • Along with being your IAR, we also initiate the building of your local presence in India
  • We put together a dedicated team who takes charge of sales partnerships and manages the nuances of business operations
  • We ā€˜Buildā€™ the infrastructure and set up processes; we ā€˜Operateā€™ the business, and when you feel ready, we ā€˜Transferā€™ the control to you